Pregnancy Point of Care Testing Market 2028 By Type, Distribution Channel and Geography | The Insight Partners

report image

Pregnancy Point of Care Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (LH Urine Test, FSH Urine Test, HCG Blood Test, HCG Urine Test); Distribution Channel (Pharmacies, Fertility Clinics, Hypermarkets and Supermarkets) and Geography

Report Code: TIPRE00017627 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming


The point of care testing is is a type of medical diagnostic testing at point of care i.e at the time and place of patient care. This testing provide very quick results. Pregnancy Point of Care Testing is used to determine whether or not a woman is pregnant and whether or not she is fertile. The components of Pregnancy Point of Care Testing precisely estimate the level of several reproductive hormones such as luteinizing hormone, follicle stimulating hormone, and GH. These kits are also useful for determining the exact day of ovulation. The advantage of a point-of-care pregnancy testing kit is that it decreases the overall time of the process, provides quick and accurate results, and allows tests to be performed without having to go to the hospital.


The "Global Pregnancy Point of Care Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the pregnancy point of care testing market with detailed market segmentation by type, and distribution channel. The report provides key statistics on the market status of the leading pregnancy point of care testing market players and offers key trends and opportunities in the market.


  •   Based on type the market is segmented as, LH urine test, FSH urine test, HCG blood test and HCG urine test.
  •   Based on distribution channel the market is segmented as, pharmacies, fertility clinics, supermarkets.


  •   Increasing technological advancements in pregnancy point of care testing is expected to support market growth during the forecast period.
  •   Rising demand for pregnancy point of care testing among urban population is expected to fuel the market growth during the forecast period.
  •   Surge in gynecological and infertility disorders is expected to spur the market growth.
  •   Increasing trend for point of care testing due to quick results is also expected to fuel market growth.


  •   Whereas, low awareness about point of care testing in developing nations is expected to hamper market growth during the forecast period.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The pregnancy point of care testing market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the pregnancy point of care testing market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the pregnancy point of care testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from pregnancy point of care testing market are anticipated to lucrative growth opportunities in the future with the rising demand for pregnancy point of care testing in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the pregnancy point of care testing market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Abbott
  •   Quidel Corporation
  •   Prestige Consumer Healthcare Inc
  •   Swiss Precision Diagnostics GmbH
  •   Biosynex
  •   EKF Diagnostics Holdings plc
  •   NOW Diagnostics
  •   Procter and Gamble Co
  •   Piramal Enterprises

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Abbott
2. Quidel Corporation
3. Prestige Consumer Healthcare Inc
4. Swiss Precision Diagnostics GmbH
5. Biosynex
6. EKF Diagnostics Holdings plc
7. NOW Diagnostics
9. Procter and Gamble Co
10. Piramal Enterprises
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount